Fulgent Genetics, Inc. FLGT Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Laboratory Services | $319.81M+9.4% | $322.22M+13.7% | $315.41M+13.6% | $303.22M+4.3% | $292.45M+1.7% | |
| Therapeutic Development | $534K— | $447K— | $138K— | $0— | $0— | |
| Revenue by Geography | ||||||
| Non Us | $26.51M+7.6% | $26.12M+1.9% | $23.83M-5.2% | $23.41M-5.6% | $24.65M+8.3% | |
| Other Countries | $13.66M+1.2% | $13.21M+1.6% | $12.41M-0.9% | $12.33M+6.8% | $13.5M+45.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Fulgent Genetics, Inc. break its business down?
- Fulgent Genetics, Inc. (FLGT) reports revenue by business across 2 parts — Laboratory Services and Therapeutic Development. Each is extracted from the segment footnotes and tracked over time.
- Where does Fulgent Genetics, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Fulgent Genetics, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
